Treatment Clinical Trials

39 recruiting

Treatment Trials at a Glance

454 actively recruiting trials for treatment are listed on ClinicalTrialsFinder across 6 cities in 51 countries. The largest study group is Not Applicable with 186 trials, with the heaviest enrollment activity in Tianjin, Shanghai, and New York. Lead sponsors running treatment studies include Institute of Hematology & Blood Diseases Hospital, China, Shanghai Juncell Therapeutics, and Centre for Addiction and Mental Health.

Treatments under study

About Treatment Clinical Trials

Looking for clinical trials for Treatment? There are currently 39 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Treatment trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Treatment clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 454 trials

Recruiting

Biorepository in Participants Who Undergo OTC for Gonadotoxic Therapy

InfertilityAcute Ovarian FailureEarly Menopause And Infertility In Females After Treatment For Childhood Cancer
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)100 enrolled1 locationNCT05440617
Recruiting
Phase 1Phase 2

Personalized Ultrasonic Brain Stimulation for Depression (R61)

Depression - Major Depressive DisorderMajor Depressive EpisodeTreatment-Resistant Major Depressive Disorder
Brian Mickey30 enrolled1 locationNCT06902298
Recruiting
Not Applicable

Child-Adult Relationship Enhancement in Primary Care (PriCARE) / Criando Niños Con CARIÑO (CARIÑO)

Parent-Child RelationsChild Maltreatment
University of North Carolina, Chapel Hill1,932 enrolled2 locationsNCT05233150
Recruiting

Natural History of Depression, Bipolar Disorder and Suicide Risk

Molecular Mechanisms of Pharmacological ActionDepressive SymptomsSuicide+17 more
National Institute of Mental Health (NIMH)500 enrolled1 locationNCT06462196
Recruiting
Phase 2

Mindfulness Engaged Neurostimulation for Depression (MEND II)

DepressionDepressive DisorderDepressive Symptoms+2 more
University of California, San Diego120 enrolled1 locationNCT07512284
Recruiting
Phase 3

Intra-arterial Tenecteplase for Acute Medium Vessel Occlusion Stroke

Ischemic StrokeMedium Vessel OcclusionEndovascular Treatment+1 more
Beijing Tiantan Hospital488 enrolled1 locationNCT07357987
Recruiting
Phase 4

Algorithm Guided Treatment Versus Treatment as Usual (TAU) for Patients With Treatment Resistant Depression

Treatment Resistant Depression (TRD)
Aalborg University Hospital80 enrolled1 locationNCT07080723
Recruiting
Phase 1

NMDA Receptor Antagonist Nitrous Oxide Targets Affective Brain Circuits

Depressive Disorder, MajorDepressive Disorder, Treatment-Resistant
Washington University School of Medicine60 enrolled1 locationNCT02994433
Recruiting
Not Applicable

Surgical Approach to Uterine Septum

TreatmentSurgical ComplicationTreatment Side Effects+2 more
Northwestern University40 enrolled1 locationNCT06315582
Recruiting

National, Non Interventional Study of Invasive Pneumococcal Disease in Children and Newborns

MortalityPneumococcal InfectionsPneumococcal Conjugate Vaccine+1 more
Association Clinique Thérapeutique Infantile du val de Marne2,500 enrolled1 locationNCT04664556
Recruiting

National Bacterial Meningitis Study in Children and Newborns

MeningitisChildren, OnlyNeonatal Infection+5 more
Association Clinique Thérapeutique Infantile du val de Marne10,000 enrolled1 locationNCT04664569
Recruiting
Not Applicable

Maintenance rTMS for Depression (Maitr-De)

Major Depressive DisorderTreatment Resistant Depression
University of California, San Diego75 enrolled3 locationsNCT06938841
Recruiting
Not Applicable

99Tc-MDP Treatment for Knee Osteoarthritis

Treatment Outcome
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine40 enrolled1 locationNCT02993029
Recruiting
Phase 2

Visugromab, Nivolumab and Lenvatinib Compared to Double Placebo and Lenvatinib in Unresectable or Metastatic Hepatocellular Carcinoma Post Anti-PD-(L)1 Failure

Unresectable or Metastatic Hepatocellular CarcinomaChild-Pugh A Hepatocellular CarcinomaFailure of First-Line Treatment That Included an Approved Anti PD-(L)1 Compound
CatalYm GmbH104 enrolled2 locationsNCT07219459
Recruiting
Not Applicable

Smoke Free SafeCare: Establishing a Smoke Free Home in CPS-involved Families

Smoking BehaviorsChild Maltreatment
Georgia State University268 enrolled1 locationNCT05000632
Recruiting
Not Applicable

Peer Recovery to Improve Polysubstance Use and Mobile Telemedicine Retention

Substance-Related DisordersTreatment AdherenceRetention in Care+2 more
University of Maryland, College Park160 enrolled4 locationsNCT05973838
Recruiting
Not Applicable

Evaluation of a Switchable Acrylic Adhesive Drape for Safer Removal in Negative Pressure Wound Therapy Applications.

Frequency and Type of Medical Adhesive-Related Skin InjuryNPWT Drape Seal Effectiveness Rate (or Leak Incidence Rate)Clinician Acceptability of New NPWT Drape+2 more
Global Biomedical Technologies, LLC300 enrolled6 locationsNCT06717308
Recruiting
Phase 2

Zanzalintinib for the Treatment of Advanced Thyroid Cancer Before Surgery

Neoadjuvant TreatmentThyroid Cancer
M.D. Anderson Cancer Center45 enrolled1 locationNCT06959511
Recruiting

Serial PSMA PET for Therapy Monitoring in Clinically Significant Prostate Cancer

Treatment ResponseHigh-risk Prostate CancerPSMA PET+1 more
Xijing Hospital110 enrolled9 locationsNCT07553780
Recruiting
Not Applicable

TaVNS for Delirium

DeliriumDelirium Treatment
Stony Brook University10 enrolled1 locationNCT07258082